Sign inJoin waitlistJoin the waitlist

Atif Hussein

Program Director, Hematology/Oncology Fellowship Program · Memorial Healthcare System, Hollywood, Florida

Credentials: · · · · ·

History

Hematology/Oncology Fellowship · Memorial Healthcare System, Hollywood, Florida
Present
East Operations - Adult Hematology and Oncology Program · Memorial Healthcare System, Hollywood, Florida
Present
Memorial Cancer Institute
Present

University of Miami/Jackson Health System
1987–1989
University of Miami/Jackson Health System
1986–1987
American University Hospital
1984–1985
Tulane University
American Univ of Beirut, Beirut, Lebanon
1980–1984

Research

Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas
Cancer · 1990 · First of 3 authors · 87 citations
Carbon dioxide insufflation for more comfortable colonoscopy
Gastrointestinal Endoscopy · 1984 · First of 3 authors · 86 citations
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support
Journal of Clinical Oncology · 1994 · 83 citations

WP
William Peters
20 papers
JV
James Vredenburgh
19 papers
MR
Maureen Ross
16 papers
PR
Peter Rubin
13 papers · 1 as a fellow
ME
Maha Elkordy
9 papers
Barry Meisenberg
7 papers
Lynn Feun
7 papers
Luis Raez
6 papers
Pasquale Benedetto
5 papers
Joanne Kurtzberg
4 papers
Marc Kesselman
4 papers
Niramol Savaraj
4 papers

Clinical trials

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Site PI · Recruiting · Phase 3
Replimune, Inc.
2024–2031
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Site PI · Recruiting · Phase 3
NRG Oncology
2017–2032
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Site PI · Recruiting · Phase 2
Alliance for Clinical Trials in Oncology
2015–2028
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Site PI · Available
Northwest Biotherapeutics